Yuantian Biotech (Tianjin) Co., Ltd. (referred to as "Yuantian Biotech") recently announced exciting news, having successfully completed a nearly 100 million yuan Pre-A+ funding round. The round saw joint investments from industrial capital partners including Beiyang Haitang Fund, Shangshi Capital, DaoTong Investment, Renai Group, and Lionbridge.  

 

This funding not only marks the company's official launch of a new journey to construct a thousand-ton production line but also drives technological iteration and market expansion as dual engines, building an industrial moat in the field of bio-enzymatic regeneration.  

 

As a pioneer in the biotech sector, Yuantian Biotech has established a capital-fueled "triple jump": starting with Innova Angel Fund's initial investment in 2023, followed by strategic support from JHT Investment in 2024, and now the collective entry of industrial capital in this round. These three funding phases, like precise baton passes in a relay race, validate the unique value of its technological approach while injecting robust momentum for scalable growth.  

 

In the global battle against plastic pollution, Yuantian Biotech is writing a groundbreaking solution with technological innovation. Facing the harsh reality of only 9% of the 400 million tons of annual plastic waste being recycled, the dual drivers of the EU's "Plastics Ban" and China's 14th Five-Year Plan are reshaping the global plastics industry. Meanwhile, strategic commitments to sustainable materials by international giants like Coca-Cola and Nestlé have further ignited downstream market demand for recycled materials.  

 

Amid this green revolution, Yuantian Biotech has demonstrated disruptive technological prowess: leveraging interdisciplinary integration of enzyme engineering, genetic engineering, bioinformatics, and fermentation engineering to develop highly efficient and specific PET-degrading enzymes.  

 

These enzymes can degrade various PET waste materials—such as polyester fabrics, beverage bottles, and PET films—under ambient temperature and pressure. Through crystallization and distillation, monomer products rPTA and rEG are obtained, which can then be polymerized to produce entirely new reborn PET (rbPET), achieving a true closed-loop plastic recycling system.  

 

Currently, Yuantian Biotech has completed product validation with multiple international brands and domestic listed companies, securing clients across industries including textiles and apparel, home furnishings, food and beverage packaging, automotive, and aerospace. The company has begun product sales and signed thousand-ton orders.  

 

In the era of carbon neutrality and the circular economy, Yuantian Biotech is wielding cutting-edge technology as its spear and industrial capital as its shield, writing a green legend from the laboratory to the global market."